All items in the Healthy Skepticism Library
All the 20545 items in the Healthy Skepticism Library are listed below in order of publication date with the most recent at the top. There are 100 items per page.
Page 23 of 206 pages ‹ First < 21 22 23 24 25 > Last ›
HSL17302
 DTC at the Crossroads: A 'Direct' Hit or Miss?
 ims 2010
 
http://www.imshealth.com/vgn/images/portal/cit_40000873/15/35/58020533DTCBrochure092204.pdf
HSL17315
 Gough IR, Dickinson I, Maddern G, Grigg M, Hillis DJ
 Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry
 MJA 2010;192:(5):293-295
 
http://www.mja.com.au/public/issues/192_05_010310/letters_010310_fm-3.html
HSL17316
 Pratt IS, Hughes CL, Slevin TJ
 Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry
 MJA 2010;192:(5):293-295
 
http://www.mja.com.au/public/issues/192_05_010310/letters_010310_fm-3.html
HSL17317
 Barnes RK.
 Winds of change: growing demands for transparency in the relationship between doctors and the pharmaceutical industry
 MJA 2010;192:(5):293-295
 
http://www.mja.com.au/public/issues/192_05_010310/letters_010310_fm-3.html
HSL17494
 Vitry A
 Reporting of Studies on New Medicines in Major Medical Journals: A Case Study in Breast Cancer
 Clinical Pharmacology & Therapeutics 2010;87:(4):398–400
 
http://www.nature.com/clpt/journal/v87/n4/abs/clpt2009278a.html
HSL17537
 Misra S, Ganzini L, Keepers G.
 Psychiatric resident and faculty views on and interactions with the pharmaceutical industry.
 Acad Psychiatry 2010 Spr;34:(2):102-8
 
http://ap.psychiatryonline.org/cgi/content/full/34/2/102
HSL17591
 Davis JJ
 The effect of placement and modality on the recall of information from pharmaceutical web sites
 Journal of Medical Marketing 2010;10:(2):99–114
 [Epub ahead of print]  
http://www.palgrave-journals.com/jmm/journal/v10/n2/abs/jmm200942a.html
HSL17592
 Seong Park J, Grow JM
 Symptom information in direct-to-consumer antidepressant advertising and college students’ perception of the lifetime risk of depression
 Journal of Medical Marketing 2010;10:(2):123–133
 [Epub ahead of print]  
http://www.palgrave-journals.com/jmm/journal/v10/n2/abs/jmm200944a.html
HSL17602
 Pettijohn CE, Rozell, EJ, Newman A
 The relationship between emotional intelligence and customer orientation for pharmaceutical salespeople: A UK perspective
 International Journal of Pharmaceutical and Healthcare Marketing 2010;4:(1):21 - 39
 
http://www.emeraldinsight.com/Insight/viewContentItem.do?contentType=Article&contentId=1852702
HSL17695
 Saddichha S
 Disease Mongering in Psychiatry: Is It Fact or Fiction?
 World Medical & Health Policy 2010;2:(1):15
 
http://www.psocommons.org/wmhp/vol2/iss1/art15
HSL17708
 Klemperer D
 Drug Research: Marketing Before Evidence, Sales Before Safety
 Dtsch Arztebl Int 2010;107:(16):277-8
 
http://www.aerzteblatt.de/int/article.asp?src=heft&id=74341
HSL17709
 Schott G, Pachl H, Limbach U, Gundert-Remy U, Ludwig W, Lieb K
 The Financing of Drug Trials by Pharmaceutical Companies and Its Consequences: Part 1. A Qualitative, Systematic Review of the Literature on Possible Influences on the Findings, Protocols, and Quality of Drug Trials
 Dtsch Arztebl Int 2010;107:(16):279-85
 
http://www.aerzteblatt.de/int/article.asp?id=74342
HSL17747
 Shankar PR.
 Doctors and pharmaceutical promotion.
 Pharos Alpha Omega Alpha Honor Med Soc 2010 Spr;73:(2):49
 
http://www.ncbi.nlm.nih.gov/pubmed/20455380
HSL17748
 Orentlicher D.
 Prescription data mining and the protection of patients' interests.
 J Law Med Ethics 2010 Mar;38:(1):74-84.
 
http://www3.interscience.wiley.com/journal/123334064/abstract?CRETRY=1&SRETRY=0
HSL17755
 Ackerly DC, Glickman SW, Schulman KA.
 Economic content in medical journal advertisements for medical devices and prescription drugs.
 Pharmacoeconomics 2010;28:(5):429-38
 
http://adisonline.com/pharmacoeconomics/pages/articleviewer.aspx?year=2010&issue=28050&article=00007&type=abstract
HSL17758
 Gostanian A
 How the FDA can overturn Wyeth v. Levine
 Am J Law Med. 2010;36:(1):248-68.
 
http://www.ncbi.nlm.nih.gov/pubmed/20481407
HSL17759
 Liang BA, Mackey T.
 Confronting conflict: addressing institutional conflicts of interest in academic medical centers.
 Am J Law Med 2010;36:(1):136-87
 
http://www.ncbi.nlm.nih.gov/pubmed/20481404
HSL17839
 Braillon A
 Whistleblowing: Neither reward, nor protection
 Journal of Public Health Policy 2010;31:278–279
 
HSL17927
 Clarke PM, Fitzgerald EM
 Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia
 eMJA 2010;192:(11):633-636
 
http://www.mja.com.au/public/issues/192_11_070610/cla11057_fm.html
HSL17977
 McGauran N, Wieseler B, Kreis J, Schüler Y-B, Kölsch H, Kaiser T
 Reporting bias in medical research - a narrative review
 Trials 2010;11:(1):37
 
http://www.trialsjournal.com/content/pdf/1745-6215-11-37.pdf
HSL18246
 Thomadsen BR, Heaton HT 2nd, Jani SK, Masten JP, Napolitano ME, Ouhib Z, Reft CS, Rivard MJ, Robin TT, Subramanian M, Suleiman OH
 Off-label use of medical products in radiation therapy: summary of the report of AAPM Task Group No.121
 Med Phys 2010;37:(5):2300-11
 
http://www.ncbi.nlm.nih.gov/pubmed/20527564
HSL18338
 Applbaum K
 Shadow science: Zyprexa, Eli Lilly and the globalization of pharmaceutical damage control
 BioSocieties 2010;5:236-255
 
http://www.palgrave-journals.com/biosoc/journal/v5/n2/abs/biosoc20105a.html
HSL18386
 Bucher HC.
 [Benefit and pitfalls in the use of data from surrogate endpoint trials for clinical decision making].
 Z Evid Fortbild Qual Gesundhwes 2010;104:(3):230-7;
 
http://www.ncbi.nlm.nih.gov/pubmed/20608252
HSL18591
 Haug JB, Raastad R, Berild D
 [Look to Norway - but for how long?]
 Tidsskriftet for Den Norske Legeforening 2010;
 
http://www.tidsskriftet.no/index.php?seks_id=1999673
HSL18661
 Kesselheim AS, Outterson K
 Fighting Antibiotic Resistance: Marrying New Financial Incentives To Meeting Public Health Goals
 Health Affairs 2010;29:(9):1689
 
http://content.healthaffairs.org/cgi/content/abstract/29/9/1689
HSL18668
 Jost TS.
 Oversight of marketing relationships between physicians and the drug and device industry: a comparative study.
 Am J Law Med 2010;36:(2-3):326-42
 
http://www.ncbi.nlm.nih.gov/pubmed/20726399
HSL18692
 Moynihan R, Mintzes B
 Sex, Lies, And Pharmaceuticals: How Drug Companies Plan To Profit From Female Sexual Dysfunction Canada: D&M Publishers Incorporate 2010
 
http://www.borders.com.au/book/sex-lies-and-pharmaceuticals-how-drug-companies-plan-to-profit-from-female-sexual-dysfunction/8987535/
HSL18723
 Fugh-Berman AJ, Scialli AR, Bell AM
 Why lunch matters: Assessing physicians' perceptions about industry relationships
 Journal of Continuing Education in the Health Professions 2010;30:(3):197-204
 
http://www.jcehp.com/vol30/3003_berman.asp
HSL18763
 The expectations, the reality and the burden of drug donations.
 Burnet Instiute 2010
 
http://www.burnet.edu.au/home/cih/resources/reports
HSL18792
 Willis M, Persson U, Zoellner Y, Gradl B.
 Reducing uncertainty in value-based pricing using evidence development agreements: the case of continuous intraduodenal infusion of levodopa/carbidopa (duodopa
 Appl Health Econ Health Policy 2010;8:(6):377-86
 
http://content.wkhealth.com/linkback/openurl?issn=1175-5652&volume=8&issue=6&spage=377
HSL18799
 Episode 8: Defender of industry-sponsored CME
 The Med AD News Show 2010
 
http://downloads.pharmalive.com/?disp=wpdetail&wpid=c16a5320fa475530d9583c34fd356ef5
HSL18800
 Episode 10: Not All Interests Are Conflicts
 The Med AD News Show 2010
 
http://downloads.pharmalive.com/?disp=wpdetail&wpid=e369853df766fa44e1ed0ff613f563bd
HSL18941
 Carlat D
 Unhinged: The Trouble with Psychiatry - A Doctor's Revelations about a Profession in Crisis : Simon & Schuster 2010
 
http://books.simonandschuster.com/Unhinged/Daniel-Carlat/9781416590798
HSL18949
 Hyer CF
 Off-label use and prescribing what does it mean for the foot and ankle surgeon?
 Foot Ankle Spec 2010;3:(5):303-6
 
www.orthofootankle.com
HSL18954
 ICH: an exclusive club of drug regulatory agencies and drug companies imposing its rules on the rest of the world.
 Prescrire Int. 2010;19:(108):183-6
 
HSL18970
 Kuehlein T, Sghedoni D, Visentin G, Gérvas J, Jamoulle M
 Quaternary prevention: a task of the general practitioner
 Primary Care 2010;(18):
 
http://www.primary-care.ch/pdf_d/2010/2010-18/2010-18-368_ELPS_engl.pdf
HSL19398
 Ching A, Ishihara M
 The effects of detailing on prescribing decisions under quality uncertainty
 Quant Mark Econ 2010;8:123–165
 
http://mpra.ub.uni-muenchen.de/8324/
HSL19261
 Chandra, R
 Incentives for Global Public Health: Patent Law and Access to Essential Medicines
 The role of national laws in reconciling constitutional right to health with TRIPS obligations: an examination of the Glivec patent case in India, Part IV, Chapter 15 Cambridge, UK: Cambridge University Press 2010381-405
 
http://ebooks.cambridge.org/chapter.jsf?bid=CBO9780511750786&cid=CBO9780511750786A029
HSL19318
 Faunce T, Urbas G, Skillen L, Smith M.
 Recovering fraudulent claims for Australian federal expenditure on pharmaceuticals and medical devices.
 J Law Med 2010;18:(2):302-15
 
http://www.ncbi.nlm.nih.gov/pubmed/21355432
HSL17928
 Parker MH
 Normative lessons: codes of conduct, self-regulation and the law
 eMJA 2010;192:(11):658-660
 
http://www.mja.com.au/public/issues/192_11_070610/par10068_fm.html
HSL19709
 Jain S
 Continuing Medical Education: How to Separate Continuing Medical Education from Pharmaceutical Industry Promotion 
 Understanding Physician-Pharmaceutical Industry Interactions A Concise Guide Cambridge: Cambridge University Press  2010
 
http://www.ebooks.cambridge.org/chapter.jsf?bid=CBO9780511665677&cid=CBO9780511665677A013
HSL16987
 Barrington KJ
 Drug firm conflicting interests: If only industry funded trials were as well done as the WHI
 BMJ 2009 Dec 31;339:
 
http://www.bmj.com/cgi/content/extract/339/dec31_1/b5655
HSL16993
 Iskowitz M
 Pharma sought safe havens for DTC in '09
 Medical Marketing & Media 2009 Dec 31
 
http://www.mmm-online.com/pharma-sought-safe-havens-for-dtc-in-09/article/160494/
HSL16994
 Shankar R
 Cervical cancer ad campaign shifted to FM Radio after DCGI's show cause notice to GSK
 PharmaBiz.com 2009 Dec 31
 
http://www.pharmabiz.com/article/detnews.asp?articleid=53336
HSL17069
 Mendoza M, Mason M
 Solution to killer superbug found in Norway
 The Associated Press 2009 Dec 31
 
http://news.yahoo.com/s/ap/20091231/ap_on_re_us/when_drugs_stop_working_norway_s_answer
HSL17077
 Author! Author! Who Should Be Named in a Published Study? An Ethics Case Study
 MedScape 2009 Dec 31;
 
http://cme.medscape.com/qna/preactivity/17033?formid=3&dest_url=http://cme.medscape.com/viewarticle/714405
HSL16984
 No Evidence that Additional Price Protection for New Drugs Increased Innovation, Study Finds
 2009 Dec 30
 
HSL16981
 Mathew JC
 Small drug firms cry foul over ethics code
 Business Standard 2009 Dec 27
 
http://www.business-standard.com/india/news/small-drug-firms-cry-foul-over-ethics-code/380840/
HSL16957
 Shankar R
 GSK undertakes to withdraw ad on cervical cancer vaccine to DCGI
 PharmaBiz.com 2009 Dec 24
 
http://www.essentialdrugs.org/indiadrug/archive/201001/msg00000.php
HSL16963
 Passarella G
 Health Plan Loses in Suit Faulting Eli Lilly's Zyprexa Marketing
 The Legal Intelligencer 2009 Dec 24
 
http://www.law.com/jsp/article.jsp?id=1202437268148&Health;_Plan_Loses_in_Suit_Faulting_Eli_Lillys_Zyprexa_Marketing
HSL16974
 Fauber J
 Journal editor gets royalties as articles favor devices
 The Journal Sentinel 2009 Dec 24
 
http://www.jsonline.com/watchdog/watchdogreports/80036277.html
HSL16964
 Whalen J
 AstraZeneca Sharpens Focus on Ethics
 The Wall Street Journal 2009 Dec 23
 
http://online.wsj.com/article/SB10001424052748704157304574611724066010600.html
HSL16975
 Seaman M
 Boston Scientific to pay $22M in payment inquiry
 The Associated Press 2009 Dec 23
 
http://seattletimes.nwsource.com/html/businesstechnology/2010578032_apusbostonscientificsettlement.html
HSL16982
 Rosenberg M
 New Year's Resolutions for the Drug Industry for 2010
 OpEdNews 2009 Dec 23
 
http://www.opednews.com/articles/New-Year-s-Resolutions-for-by-Martha-Rosenberg-091223-751.html
HSL16947
 Silverman E
 AstraZeneca Is ‘More Sensitive’ About Illegal Marketing
 Pharmalot 2009 Dec 22
 
http://www.pharmalot.com/2009/12/astrazeneca-is-more-sensitive-about-illegal-marketing/
HSL16961
 Grant B
 NIH's New Year's resolution?
 The Scientist 2009 Dec 22
 
http://www.the-scientist.com/blog/display/56229/
HSL16962
 O’Dowd A
 Watchdog criticises drug company for misleading promotional material
 BMJ 2009 Dec 22;339:
 
http://www.bmj.com/cgi/content/extract/339/dec22_2/b5618
HSL16979
 Mack J
 Shire Implements First Ever Integrated Phone-Assisted Social Network Marketing Campaign for ADHD!
 Pharma Marketing Blog 2009 Dec 22
 
http://pharmamkting.blogspot.com/2009/12/shire-implements-first-ever-integrated.html
HSL16955
 Chaudhry P, Stumpf S
 The CMO's Role in Curtailing Black-Market Counterfeits
 The Advertising Age 2009 Dec 21
 
http://adage.com/cmostrategy/article?article_id=141187
HSL16956
 Spiegel A
 How A Bone Disease Grew To Fit The Prescription
 npr 2009 Dec 21
 
http://www.npr.org/templates/story/story.php?storyId=121609815
HSL16945
 Hogstrom E
 The side effects
 The Telegraph Herald 2009 Dec 20
 
http://www.accessdubuque.com/forums/Comments.cfm?article=267339&MainSection=News%20Stories&newonly=true
HSL16965
 Roe S, Jewett C
 Tighter rules sought for anti-psychotic drug use in nursing homes
 The Chicago Tribune 2009 Dec 20
 
http://www.chicagotribune.com/health/chi-psychotropics-reformdec20,0,3977364.story
HSL16966
 Gerth J
 Libel gag on talk of 'medical hurricane'
 The Sunday Times 2009 Dec 20
 
http://business.timesonline.co.uk/tol/business/law/article6962816.ece
HSL16977
 Wipatayotin A
 Muzzling the drug giants
 Bangkok Post 2009 Dec 20
 
http://www.bangkokpost.com/news/local/29549/muzzling-the-drug-giants
HSL17132
 Singer N
 Cancer Center Ads Appeal to Emotions at a Fragile Time
 The New York Times 2009 Dec 19
 
http://www.nytimes.com/2009/12/19/health/19cancerads.html?_r=2&th;=&emc=th&pagewanted=all
HSL16948
 Silverman E
 A Pfizer Whistleblower Tops Business Ethics List
 Pharmalot 2009 Dec 18
 
http://www.pharmalot.com/2009/12/a-pfizer-whistleblower-tops-business-ethics-list/
HSL16959
 Camargo Jr KR.
 Public health and the knowledge industry.
 Rev Saude Publica 2009 Dec 18;
 
http://www.scielosp.org/scielo.php?script=sci_arttext&pid=S0034-89102009005000076&lng=en&nrm=iso&tlng=en
HSL17288
 Kientop D
 Integrating Medical Science Liaisons into Key Account Management
 Journal of Medical Marketing 2009 Dec 18;10:(1):45–51
 
http://www.palgrave-journals.com/jmm/journal/v10/n1/abs/jmm200945a.html
HSL16936
 Morris L, Taitsman JK
 The Agenda for Continuing Medical Education— Limiting Industry’s Influence
 NEJM 2009 Dec 17;361:(25):2478-2482
 
http://content.nejm.org/cgi/content/short/361/25/2478?query=TOC
HSL16973
 Arnold M
 AstraZeneca airs
 Medical Marketing & Media 2009 Dec 17
 
http://www.mmm-online.com/astrazeneca-airs-consuming-consumer-for-seroquel-xr-bipolar-depression/article/159860/
HSL16980
 A Big Bad Biotech Case and its Effects on Qui Tam
 The Qui Tam Team Blog 2009 Dec 17
 
http://quitamteam.com/blog/big-bad-biotech-case-effects-qui-tam/
HSL17005
 Coalition for a Competitive Pharmaceutical Market Runs Ads Stating Congress Is Giving 'Greatest Holiday Gift of All to Brand Pharmaceutical Companies'
 Pharmalive 2009 Dec 17
 
http://pharmalive.com/news/index.cfm?articleID=674501
HSL17007
 Harris G
 Advisers on Vaccines Often Have Conflicts, Report Says
 The New York Times 2009 Dec 17
 
http://www.nytimes.com/2009/12/18/health/policy/18cdc.html?_r=1
HSL16943
 Rasmussen N, Lee K, Bero L.
 Association of trial registration with the results and conclusions of published trials of new oncology drugs.
 Trials 2009 Dec 16;10:(1):116
 
http://www.trialsjournal.com/content/10/1/116
HSL16972
 Atypical Antipsychotics For Depression: Now With
 Clinical Psychology and Psychiatry: A Closer Look 2009 Dec 16
 
http://clinpsyc.blogspot.com/2009/12/atypical-antipsychotics-for-depression.html
HSL17091
 Arnold M
 TV viewers suffer risk info overload from pharma ads
 Medical Marketing & Media 2009 Dec 16
 
http://www.mmm-online.com/tv-viewers-suffer-risk-info-overload-from-pharma-ads/article/160480/
HSL16944
 Gilheany MF, Borthwick AM.
 Recent developments in podiatric prescribing in the UK and Australia.
 J Foot Ankle Res 2009 Dec 15;2:(1):37
 
http://www.jfootankleres.com/content/2/1/37
HSL16949
 O’Reilly C, Feeley J
 Pfizer Seeks Prempro Video’s Removal From Internet (Update2)
 Bloomberg.com 2009 Dec 15
 
http://www.bloomberg.com/apps/news?pid=20601202&sid=awHcMJRomj_Q
HSL16950
 Silverman E
 NAMI Runs A Survey On Pharma Funding
 Pharmalot 2009 Dec 15
 
http://www.pharmalot.com/2009/12/nami-runs-a-survey-on-pharma-funding/
HSL16951
 Silverman E
 Pharma, Conflicts Of Interest And Fingerpointers
 Pharmalot 2009 Dec 15
 
http://www.pharmalot.com/2009/12/pharma-conflicts-of-interest-and-fingerpointers/
HSL16967
 Dyer C
 Aubrey Blumsohn: Academic who took on industry
 BMJ 2009 Dec 15;339:
 
http://www.bmj.com/cgi/content/short/339/dec15_1/b5293
HSL16976
 Treerutkuarkul A
 Companies accused of 'pushing' drugs: Doctors back efforts to regulate promotions
 Bangkok Post 2009 Dec 15
 
http://www.bangkokpost.com/news/local/29264/companies-accused-of-pushing-drugs
HSL17008
 Edwards J
 GSK's $1B Paxil Problem Highlights Murky Disclosures From Euro Drug Companies
 BNet 2009 Dec 15
 
http://industry.bnet.com/pharma/10005807/gsks-1b-paxil-problem-highlights-murky-disclosures-from-euro-drug-companies/
HSL17009
 Drug makers quicker to embrace settlements to delay low-cost generics
 The San Francisco Business Times 2009 Dec 15
 
http://www.bizjournals.com/sanfrancisco/stories/2009/12/14/focus1.html?b=1260766800^2567781
HSL16953
 Silverman E
 Glaxo Publishes List Of Fees Paid To Doctors
 Pharmalot 2009 Dec 14
 
http://www.pharmalot.com/2009/12/glaxo-publishes-list-of-fees-paid-to-doctors/
HSL16954
 Feeley J, Cronin Fisk M
 Glaxo Said to Have Paid $1 Billion in Paxil Suits (Update2)
 Bloomberg.com 2009 Dec 14
 
http://www.bloomberg.com/apps/news?pid=20601202&sid=aEr_s70bGdYo
HSL16971
 Heavey S
 UPDATE 1-Drug data mining ban unlikely in Senate health bill
 Reuters 2009 Dec 14
 
http://www.reuters.com/article/idUSN1413386820091215
HSL17049
 Aronson JK
 Patent medicines and secret remedies
 BMJ 2009 Dec 14;
 
http://www.bmj.com/cgi/content/full/339/dec14_1/b5415
HSL16940
 Singer N, Wilson D
 Menopause, as Brought to You by Big Pharma
 The New York Times 2009 Dec 13
 
http://www.nytimes.com/2009/12/13/business/13drug.html?_r=1
HSL16941
 Singer N
 Sure, It’s Treatable. But Is It a Disorder?
 The New York Times 2009 Dec 13
 
http://www.nytimes.com/2009/12/13/business/13stream.html
HSL17289
 Hutchings A
 Rewarding innovation? An assessment of the factors that affect price and reimbursement status in Europe
 Journal of Medical Marketing 2009 Dec 13;10:(1):83–90
 
http://www.palgrave-journals.com/jmm/journal/v10/n1/abs/jmm200949a.html
HSL16929
 HC seeks govt reply on plea against new vaccines
 The Times of India 2009 Dec 12
 
http://timesofindia.indiatimes.com/city/delhi/HC-seeks-govt-reply-on-plea-against-new-vaccines/articleshow/5328812.cms
HSL17342
 Pringle E
 US Kids Represent Psychiatric Drug Goldmine
 truthout 2009 Dec 12
 
http://www.truthout.org/1213091
HSL16927
 Alexander J
 Uniform Code on pharma marketing practices ineffective with no binding clause on cos
 PharmaBiz.com 2009 Dec 11
 
http://www.pharmabiz.com/article/detnews.asp?articleid=53032
HSL16928
 Perrone M
 Sens. move to block drugmakers from mining Rx data
 The Associated Press 2009 Dec 11
 
http://www.rdmag.com/News/FeedsAP/2009/12/life-sciences-sens-move-to-block-drugmakers-from-mining-rx-data/
HSL16931
 Shankar P
 Privilege motion likely against chemicals minister on Uniform Code for drug marketing
 PharmaBiz.com 2009 Dec 11
 
http://saffron.pharmabiz.com/article/detnews.asp?articleid=53033§ionid=43&z=y
HSL16978
 Edwards J
 Millions Take Aspirin to Prevent Heart Attacks Based on a Typo; 'Immodest' Bayer Site Not Helping
 BNet 2009 Dec 11
 
http://industry.bnet.com/pharma/10005775/did-a-typo-cause-millions-to-take-aspirin-to-prevent-heart-attacks-immodest-bayer-site-not-helping/
HSL17356
 Singh K
 Small pharma cos oppose self-regulation for industry, want rules
 The Economic Times 2009 Dec 11
 
http://economictimes.indiatimes.com/news/news-by-industry/healthcare/biotech/pharmaceuticals/Small-pharma-cos-oppose-self-regulation-for-industry-want-rules/articleshow/5324825.cms
HSL17050
 Godlee F
 We want raw data, now
 BMJ 2009 Dec 10;
 
http://www.bmj.com/cgi/content/full/339/dec10_2/b5405
HSL16917
 The Associated Press
 EU raids drug makers in antitrust probe
 Business Week 2009 Dec 9
 
http://www.businessweek.com/ap/financialnews/D9CFRRAG0.htm
Page 23 of 206 pages ‹ First < 21 22 23 24 25 > Last ›
 








 


